T

Stroke workspace

Evidence
Clinician-reviewed CDS · Browser-local · No identifiers · Source-linkedRead more…

This tool is educational and informational. It does not replace clinical judgment. Verify trial populations, sICH definitions, BP target ranges, and post-treatment monitoring against the cited source before acting.

Not prospectively validated. No clinical tool replaces bedside assessment.

This tool qualifies as non-device clinical decision support under the January 2026 FDA CDS guidance (21st Century Cures Act §3060). It does not acquire or analyze patient data, it displays the basis for its recommendations, it enables independent clinician review, and it is intended for use by trained healthcare professionals.

This runs entirely in your browser; we store nothing. Even so, enter only clinical data (age, vitals, exam findings) -- not names, MRNs, or other identifiers.

Tarvinder Singh, MD -- Vascular Neurologist. March 2026.

Acute Ischemic Stroke

IVT and EVT eligibility by time window, imaging, and contraindication profile against AHA/ASA 2026 guidelines and stroke trial evidence.

New here? Try a demo case below to see the full IVT / EVT recommendation stack in under 30 seconds.
Time from LKW, CT, age, NIHSS, BP, vessel, ASPECTS -- ordered by what unlocks the next decision.
CT head result
mRS scale reference
0
No symptoms.
1
No significant disability; able to carry out usual activities despite some symptoms.
2
Slight disability; unable to carry out all previous activities but able to look after own affairs.
3
Moderate disability; requires some help but able to walk unassisted.
4
Moderately severe disability; unable to walk / attend bodily needs without assistance.
5
Severe disability; bedridden, incontinent, requires constant nursing care.

BP < 185/110 After Treatment Attempt?

This is the only BP question the IVT gate needs here. Use Yes once the pressure is below threshold after treatment or clearly controllable with IV antihypertensives.

Step 1b: Lab Gate

Common IVT lab blockers still need review.

Glucose (mg/dL)

Platelets (K/uL)

INR

Major mass effect / midline shift
AHA/ASA 2026 acute ischemic stroke guidelineStroke Evidence Map

What To Enter Next

Start with the core IVT screen fields.

Core IVT Screen

AgeLast known well / onset timeNIHSSCT head resultBP <185/110 after treatment?

EVT And Evidence Refinement

Pre-stroke mRSVessel imaging / CTA resultASPECTSGlucosePlateletsINR

IV Thrombolysis (IVT)

Awaiting core screen data

Start with age, last known well, NIHSS, CT head result, and whether BP is below 185/110 after treatment.

Mechanical Thrombectomy (EVT)

Awaiting core screen data

Then add vessel imaging, ASPECTS, and transfer capability to tighten EVT candidacy and evidence support.